SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Select Medical Holdings Corp – ‘8-K’ for 3/31/20

On:  Tuesday, 3/31/20, at 4:34pm ET   ·   For:  3/31/20   ·   Accession #:  1104659-20-41197   ·   File #:  1-34465

Previous ‘8-K’:  ‘8-K’ on / for 3/4/20   ·   Next:  ‘8-K’ on / for 4/3/20   ·   Latest:  ‘8-K’ on / for 5/2/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/20  Select Medical Holdings Corp      8-K:8,9     3/31/20   11:244K                                   Toppan Merrill/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     10K 
11: R1          Cover                                               HTML     49K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- tm2014355-1_8k_htm                  XML     15K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- sem-20200331_lab                      XML     96K 
 5: EX-101.PRE  XBRL Presentations -- sem-20200331_pre               XML     64K 
 3: EX-101.SCH  XBRL Schema -- sem-20200331                          XSD     12K 
 7: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    34K 
10: ZIP         XBRL Zipped Folder -- 0001104659-20-041197-xbrl      Zip     12K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C:   C:   C:   C:   C:   C: 
 i 0001320414  i false 0001320414 2020-03-30 2020-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM  i 8-K

 

current report

 

Pursuant to Section 13 or 15(d) of the

 

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  i March 31, 2020

 

 

 

 i SELECT MEDICAL HOLDINGS CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

 i Delaware   i 001-34465   i 20-1764048
(State or other jurisdiction of
Incorporation)
  (Commission File
Number)
  (I.R.S. Employer
Identification No.)

 

 

 

 i 4714 Gettysburg Road,  i P.O. Box 2034

 i Mechanicsburg,  i PA  i 17055

(Address of principal executive offices)  (Zip Code)

 

( i 717)  i 972-1100

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
 i Common Stock, par value $0.001 per share  i SEM  i New York Stock Exchange (NYSE)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 i ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether either registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  i ¨

 

If an emerging growth company, indicate by check mark if either registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

  

 

 

 C: 

 

 

 

Item 8.01 Other Events.

 

On March 31, 2020, Select Medical Holdings Corporation (the “Company”) announced a change in the location of the Company’s 2020 Annual Meeting of Stockholders to be held on Tuesday, April 28, 2020 (the “Annual Meeting”). A copy of the press release announcing the location change is attached hereto as Exhibit 99.1 and is incorporated by reference herein. Further information regarding this change to the location of the Annual Meeting can be found in the proxy supplement filed by the Company with the Securities and Exchange Commission on March 31, 2020.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit Number Description
   
99.1 Press Release, dated March 31, 2020, announcing a change in the location of Select Medical Holdings Corporation’s 2020 Annual Meeting of Stockholders.
   
104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

 

  SELECT MEDICAL HOLDINGS CORPORATION
   
Date: March 31, 2020 By:   /s/ Michael E. Tarvin
    Michael E. Tarvin
    Executive Vice President, General Counsel and Secretary

 

 C: 

 

 

 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
4/28/204,  8-K,  DEF 14A
Filed on / For Period end:3/31/2010-Q,  DEFA14A
 List all Filings 
Top
Filing Submission 0001104659-20-041197   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 1:00:55.1pm ET